Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
6,500,794
-
Total 13F shares
-
8,609,574
-
Share change
-
+625,179
-
Total reported value
-
$289,376,415
-
Price per share
-
$33.62
-
Number of holders
-
75
-
Value change
-
+$20,624,459
-
Number of buys
-
53
-
Number of sells
-
32
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) as of Q2 2021
As of 30 Jun 2021,
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,609,574 shares.
The largest 10 holders included
FRED ALGER MANAGEMENT, LLC, ArrowMark Colorado Holdings LLC, BlackRock Inc., FRANKLIN RESOURCES INC, PERCEPTIVE ADVISORS LLC, Point72 Asset Management, L.P., BVF INC/IL, VANGUARD GROUP INC, SUVRETTA CAPITAL MANAGEMENT, LLC, and Woodline Partners LP.
This page lists
75
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.